149 related articles for article (PubMed ID: 6319290)
1. A wild and an attenuated strain of Francisella tularensis differ in susceptibility to hypochlorous acid: a possible explanation of their different handling by polymorphonuclear leukocytes.
Löfgren S; Tärnvik A; Thore M; Carlsson J
Infect Immun; 1984 Feb; 43(2):730-4. PubMed ID: 6319290
[TBL] [Abstract][Full Text] [Related]
2. Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes.
Löfgren S; Tärnvik A; Bloom GD; Sjöberg W
Infect Immun; 1983 Feb; 39(2):715-20. PubMed ID: 6832815
[TBL] [Abstract][Full Text] [Related]
3. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes.
Sandström G; Löfgren S; Tärnvik A
Infect Immun; 1988 May; 56(5):1194-202. PubMed ID: 3356465
[TBL] [Abstract][Full Text] [Related]
4. Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape.
McCaffrey RL; Allen LA
J Leukoc Biol; 2006 Dec; 80(6):1224-30. PubMed ID: 16908516
[TBL] [Abstract][Full Text] [Related]
5. Temporal appearance of opsonizing antibody to Francisella tularensis: detection by a radiometabolic assay.
Canonico PG; McManus AT; Mangiafico JA; Sammons LS; McGann VG; Dangerfield HG
Infect Immun; 1975 Mar; 11(3):466-9. PubMed ID: 234915
[TBL] [Abstract][Full Text] [Related]
6. Basis for the failure of Francisella tularensis lipopolysaccharide to prime human polymorphonuclear leukocytes.
Barker JH; Weiss J; Apicella MA; Nauseef WM
Infect Immun; 2006 Jun; 74(6):3277-84. PubMed ID: 16714555
[TBL] [Abstract][Full Text] [Related]
7.
Heine HS; Miller L; Halasohoris S; Purcell BK
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674048
[No Abstract] [Full Text] [Related]
8. [Geographical difference in susceptibility to macrolide antibiotics among naturally occurring strains of Francisella tularensis (author's transl)].
Ohara S; Sato T; Homma M
Nihon Saikingaku Zasshi; 1978; 33(2):415-20. PubMed ID: 671743
[No Abstract] [Full Text] [Related]
9. In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis.
Johansson A; Urich SK; Chu MC; Sjöstedt A; Tärnvik A
Scand J Infect Dis; 2002; 34(5):327-30. PubMed ID: 12069013
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
Tomaso H; Hotzel H; Otto P; Myrtennäs K; Forsman M
J Antimicrob Chemother; 2017 Sep; 72(9):2539-2543. PubMed ID: 28605439
[TBL] [Abstract][Full Text] [Related]
11. Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes.
Proctor RA; White JD; Ayala E; Canonico PG
Infect Immun; 1975 Jan; 11(1):146-51. PubMed ID: 234911
[TBL] [Abstract][Full Text] [Related]
12. Broth microdilution susceptibility testing of Francisella tularensis: quality control limits for nine antimicrobial agents and three standard quality control strains.
Brown SD; Krisher K; Traczewski MM
J Clin Microbiol; 2004 Dec; 42(12):5877-80. PubMed ID: 15583330
[TBL] [Abstract][Full Text] [Related]
13. Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain.
Aperis G; Fuchs BB; Anderson CA; Warner JE; Calderwood SB; Mylonakis E
Microbes Infect; 2007 May; 9(6):729-34. PubMed ID: 17400503
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth.
Baker CN; Hollis DG; Thornsberry C
J Clin Microbiol; 1985 Aug; 22(2):212-5. PubMed ID: 4031036
[TBL] [Abstract][Full Text] [Related]
15. Killing of Coccidioides immitis by hypochlorous acid or monochloramine.
Galgiani JN
J Med Vet Mycol; 1990; 28(2):173-81. PubMed ID: 2166156
[TBL] [Abstract][Full Text] [Related]
16. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals.
Ikäheimo I; Syrjälä H; Karhukorpi J; Schildt R; Koskela M
J Antimicrob Chemother; 2000 Aug; 46(2):287-90. PubMed ID: 10933655
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivity of Hungarian strains of Francisella tularensis to antibiotics].
Füzi M; Kemenes F
Orv Hetil; 1972 Aug; 113(35):2103-5. PubMed ID: 5051095
[No Abstract] [Full Text] [Related]
18. Demonstration of opsonizing antibodies to Francisella tularensis by leukocyte chemiluminescence.
Löfgren S; Tärnvik A; Carlsson J
Infect Immun; 1980 Aug; 29(2):329-34. PubMed ID: 7216416
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of 71 French isolates of Francisella tularensis subsp. holarctica to eight antibiotics and accuracy of the Etest method.
Valade E; Vaissaire J; Mérens A; Hernandez E; Gros C; Le Doujet C; Paucod JC; Thibault FM; Durand B; Lapalus M; Dupuis I; Caclard A; Vidal DR; Cavallo JD
J Antimicrob Chemother; 2008 Jul; 62(1):208-10. PubMed ID: 18397924
[No Abstract] [Full Text] [Related]
20. [The characteristics of a natural attenuated isolate of Francisella tularensis].
Kormilitsyna MI; Meshcheriakova IS
Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):3-6. PubMed ID: 8701651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
